Abbott clinical biochemically activated aspartate transaminase assay set - Taiwan Registration 1d08001a3e73e62c8174ee5798bd0ea6
Access comprehensive regulatory information for Abbott clinical biochemically activated aspartate transaminase assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1d08001a3e73e62c8174ee5798bd0ea6 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used to quantify aspartate aminotransferase in human serum or plasma on the ARCHITECT c system.
A Clinical chemistry and clinical toxicology
A.1100 ๅคฉ้ๅฌ่บ้ ธ่ฝ่บ้ ถ่ฉฆ้ฉ็ณป็ตฑ
QMS/QSD;; ่ผธๅ ฅ
Dates and Status
Jan 12, 2022
Jan 12, 2027

